Co-Administration of Novel Oral Polio Vaccine Type 2 and Bivalent Oral Polio Vaccine: Current Evidence, Challenges, and Implications for the Polio Eradication Endgame. [PDF]
Bateyi Mustafa SH +3 more
europepmc +1 more source
Neutralizing Activity of Vaccine-Induced Antibodies Against Vaccine-Derived Polioviruses Type 2. [PDF]
Karpova EV +8 more
europepmc +1 more source
According to manufacturers, inactivated poliovirus vaccines (IPVs) are freeze sensitive and require storage between 2\ub0C and 8\ub0C, whereas oral poliovirus vaccine requires storage at -20\u202f\ub0C.
core
Editorial: Eradicating polio in Pakistan and other countries in the Eastern Mediterranean region: epidemiology, surveillance, and immunization. [PDF]
Mbaeyi C +3 more
europepmc +1 more source
Response to a vaccine-derived poliovirus type 1 event - Sichuan, China, 2024. [PDF]
Yang Q +8 more
europepmc +1 more source
Changed frequency of enterovirus hospitalisations after change of polio vaccination scheme: a nation-wide cohort study from Denmark. [PDF]
Johannesen CK +4 more
europepmc +1 more source
Commemorating the Centenary of Fangzhou Gu. [PDF]
Song Q, Liang Y, Shi J, Wang Y.
europepmc +1 more source
Immunogenicity and Safety of a Single Booster Dose of Sabin-Strain Inactivated Poliovirus Vaccine in Adolescents and Adults: A Phase IV, Open-Label Trial. [PDF]
Zhang X +11 more
europepmc +1 more source
Generation and Characterization of Single-Domain Antibodies Against the D-Antigen of Sabin Poliovirus Types 2 and 3. [PDF]
Ermakova M +11 more
europepmc +1 more source
Complete genome sequences of eight poliovirus Sabin 2-derived and five novel oral poliovirus 2-derived circulating vaccine-derived poliovirus (CVDPV) genomes with single-end recombination from Botswana, 2022-2023. [PDF]
Castro CJ +5 more
europepmc +1 more source

